WestCoastSummit WestCoastSummit

West Coast Diagnostics Summit

ACLA and AdvaMedDx have teamed up to sponsor a first-of-its-kind diagnostic summit this fall in San Diego. 

newspaperslider newspaperslider

Senate Health Leadership Reacts to FDA Laboratory Developed Test (LDT) Oversight

shutterstock_193931348 shutterstock_193931348

The American Clinical Laboratory Association Commends Senate HELP Committee for Continuing Dialogue on Value of LDTs

shutterstock_193931348 shutterstock_193931348

ACLA Commends Senate Effort to Combat Proposed Gapfill Measures, Protect Medicare Patient Access to Advanced Diagnostic Tests

JoinACLA_banner JoinACLA_banner


Learn about the benefits of joining the nation’s leading advocacy organization for clinical laboratories.

pama slider pama slider

The Protecting Access to Medicare Act of 2014

Big changes are coming to how Medicare pays for clinical lab services – here’s everything your lab needs to know about the new law. 

Learn More »

View all news & updates » Recent News & Updates

View all news & updates »

Policy Issues

  • Reimbursement and Coverage

    Medicare cuts to clinical labs threaten jobs, stifle innovation, and put patient access to vital lab tests at risk.

    Continue Reading »

  • Laboratory Developed Tests

    FDA regulation of laboratory-developed tests (LDTs) is duplicative, outside of FDA jurisdiction, and would negatively impact patient access to vital lab tests.

    Continue Reading »

  • IOAS Exception

    Self-referral leads to over-utilization, mistreated patients, and billions of wasted Medicare dollars. It’s time to close the loophole.

    Continue Reading »

View all policy issues »